Combined SNP microarray and MLPA reveals genetic variations in childhood BCP-ALL, suggesting improved treatment strategies.
This study demonstrates the utility of combined SNP 6.0 microarray and MLPA in providing a comprehensive and refined understanding of the genetic landscape of BCP-ALL in the Malaysian population. This understanding may facilitate risk stratification and the development of personalized treatment strategies.
No takes yet. Share an insight, caveat, or question.
Dali et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: